跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RHINOCORT HAYFEVER & ALLERGY EXTRA STRENGTH budesonide 64 ug actuation nasal spray suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
RHINOCORT HAYFEVER & ALLERGY EXTRA STRENGTH budesonide 64 ug actuation nasal spray suspension bottle
Approved
STANDARD
RHINOCORT HAYFEVER & ALLERGY EXTRA STRENGTH budesonide 64 ug actuation nasal spray suspension bottle
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
3d2c01dcf6951485
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
3d2c01dcf6951485
Product Name
RHINOCORT HAYFEVER & ALLERGY EXTRA STRENGTH budesonide 64 ug actuation nasal spray suspension bottle
Artg Id
317846
Artg Name
RHINOCORT HAYFEVER & ALLERGY EXTRA STRENGTH budesonide 64 ug actuation nasal spray suspension bottle
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
2019-05-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
3d2c01dcf6951485
Type
Standard
Back to TGA Approvals